Adefovir Dipivoxil Tablet
Product Images NDC 60505-3947

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Adefovir Dipivoxil (NDC 60505-3947). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adefovir-dipivoxil (Adefovir Dipivoxil)

FDA Label Image

Draft-carton-10mg-30s (Draft Carton 10mg 30s)

Draft-carton-10mg-30s (Draft Carton 10mg 30s)
This is a description for Adefovir Dipivoxil tablets. However, the text contains some errors and incomplete words which may impact the accuracy and usefulness of the description.*
FDA Label Image

Draft-label-10mg-30s (Draft Label 10mg 30s)

Draft-label-10mg-30s (Draft Label 10mg 30s)
This is a medication packaging for Adefovir Dipivoxil tablets. Each tablet contains 10mg of the medication. The tablets should be stored in the original container at a temperature range of 20°C to 25°C, with excursions permitted at a range of 16°C to 30°C. The dosage and other information can be found in the package insert. The tablets are manufactured by Apotex Inc. in Toronto, Canada and distributed by Apotex Corp. in Weston, Florida.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.